Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Marine Pollution Bulletin|May 14, 2014
Isolation of 12 microsatellite markers following a pyrosequencing procedure and cross-priming in two invasive cryptic species, Alexandrium catenella (group IV) and A. tamarense (group III) (Dinophyceae)Martin Laporte, Zhaojun Shao, Patrick Berrebi, et al.Marine Drugs|November 19, 2014
Beta-N-methylamino-L-alanine: LC-MS/MS optimization, screening of cyanobacterial strains and occurrence in shellfish from Thau, a French Mediterranean lagoonDamien Réveillon, Eric Abadie, Véronique Séchet, et al.Toxins|January 20, 2016
Exposure to the Paralytic Shellfish Toxin Producer Alexandrium catenella Increases the Susceptibility of the Oyster Crassostrea gigas to Pathogenic VibriosCelina Abi-Khalil, Carmen Lopez-Joven, Eric Abadie, et al.Marine Drugs|September 26, 2015
Effect of Nitrate, Ammonium and Urea on Growth and Pinnatoxin G Production of Vulcanodinium rugosumEric Abadie, Lamia Kaci, Tom Berteaux, et al.Toxins|May 11, 2016
Toxin and Growth Responses of the Neurotoxic Dinoflagellate Vulcanodinium rugosum to Varying Temperature and SalinityEric Abadie, Alexia Muguet, Tom Berteaux, et al.Environmental Science & Technology|July 28, 2016
Passive Sampling and High Resolution Mass Spectrometry for Chemical Profiling of French Coastal Areas with a Focus on Marine BiotoxinsZita Zendong, Samuel Bertrand, Christine Herrenknecht, et al.Toxicon : Official Journal of the International Society on Toxinology|April 9, 2014
Extended evaluation of polymeric and lipophilic sorbents for passive sampling of marine toxinsZita Zendong, Christine Herrenknecht, Eric Abadie, et al.European Heart Journal|July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approvalJeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 8, 2009
Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal ProductsJohn Joseph Borg, Jean-Louis Robert, George Wade, et al.The Oncologist|April 6, 2012
The European Medicines Agency review of cabazitaxel (Jevtana®) for the treatment of hormone-refractory metastatic prostate cancer: summary of the scientific assessment of the committee for medicinal products for human useElias Pean, Pierre Demolis, Alexandre Moreau, et al.Pageof 7